Skip to main content
Top
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study

Authors: Josep Darbà, Lisette Kaskens, Nuria Pérez-Álvarez, Santiago Palacios, José Luis Neyro, Javier Rejas

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

To estimate the disability-adjusted life years (DALY) in a nationwide representative sample of postmenopausal women with osteoporosis. The effects of drug-based therapy and risk factors for osteoporotic bone fractures on DALY losses were also explored.

Methods

DALY were estimated based on participant’s clinical characteristics and Health-Related Quality-of-Life (HRQoL) data obtained from a cross-sectional, epidemiological one-visit study (the GINERISK study). The study enrolled postmenopausal women (at least 12-months after their last menstrual period) with osteoporosis, above 18-years old, who attended Spanish outpatient Gynaecology clinics. HRQoL was assessed using the generic SF-12v2 questionnaire, which was used to derive disutility values. Mortality rates were extracted from the Spanish national statistics database. Factors explored to be associated with DALY losses were examined using ANOVA, ANCOVA and MANCOVA models.

Results

DALY could be computed in 2,782 (67%) out of 4,157 postmenopausal women, with a mean (95% CI) age of 61.0 (60.7-61.2) years. Overall individual undiscounted DALY per woman were 6.1 (5.9-6.2), resulting to be significantly higher in women with severe osteoporosis with prior bone fracture; 7.8 (7.2-8.4) compared to osteoporotic women [5.8 (5.6-6.0)] or postmenopausal women with a BMD > −2.5 T-score that received a drug-based therapy [6.2 (5.8-6.5)]; F = 27.0 (P < 0.01). Models explaining the variation in the levels of health based on the use of a selective estrogen receptor modulator (SERM) or possession of risk factors for osteoporotic BF were found (P < 0.05).

Conclusions

DALY losses were considerable amongst postmenopausal women with osteoporosis. Not having a prior bone fracture, being older, using a SERM and having less osteoporotic risk factors were all linked to less DALY losses.
Literature
1.
go back to reference National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. p. 1–3. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. p. 1–3.
2.
go back to reference Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict ocurrence of osteoporotic fractures. BMJ. 1996;312:1254–9.CrossRefPubMedPubMedCentral Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict ocurrence of osteoporotic fractures. BMJ. 1996;312:1254–9.CrossRefPubMedPubMedCentral
3.
go back to reference Azagra R, Roca G, Encabo G, Prieto D, Aguyé A, Zwart M, et al. Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain. BMC Musculoskelet Disord. 1996;12:30.CrossRef Azagra R, Roca G, Encabo G, Prieto D, Aguyé A, Zwart M, et al. Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain. BMC Musculoskelet Disord. 1996;12:30.CrossRef
4.
go back to reference Palacios S, Borrego RS, Forteza A. The importance of preventive health care in post-menopausal women. Maturitas. 2005;52 Suppl 1:S53–60.CrossRefPubMed Palacios S, Borrego RS, Forteza A. The importance of preventive health care in post-menopausal women. Maturitas. 2005;52 Suppl 1:S53–60.CrossRefPubMed
5.
go back to reference Ferrer J, Neyro JL, Estevez A. Identification of risk factors for prevention and early diagnosis of a-symptomatic post-menopausal women. Maturitas. 2005;52 Suppl 1:S7–22.CrossRefPubMed Ferrer J, Neyro JL, Estevez A. Identification of risk factors for prevention and early diagnosis of a-symptomatic post-menopausal women. Maturitas. 2005;52 Suppl 1:S7–22.CrossRefPubMed
6.
go back to reference WHO Scientific Group. Prevention and Management of Osteoporosis. In: WHO Technical Report Series; 921. Geneva, Switzerland: World Health Organization; 2003. p. 2–5. WHO Scientific Group. Prevention and Management of Osteoporosis. In: WHO Technical Report Series; 921. Geneva, Switzerland: World Health Organization; 2003. p. 2–5.
7.
go back to reference Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int. 2002;13:527–36.CrossRefPubMed Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int. 2002;13:527–36.CrossRefPubMed
8.
go back to reference Kanis JA, Melton 3rd LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. Bone Miner Res. 1994;9:1137–41.CrossRef Kanis JA, Melton 3rd LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. Bone Miner Res. 1994;9:1137–41.CrossRef
9.
go back to reference Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. WHO Technical Report Series; 843. Geneva, Switzerland: World Health Organization. 1994:5. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. WHO Technical Report Series; 843. Geneva, Switzerland: World Health Organization. 1994:5.
10.
go back to reference Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581–9.CrossRefPubMed Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581–9.CrossRefPubMed
11.
go back to reference Viswanathan HN, Curtis JR, Yu J, White J, Merinar C, Stolshek BS, et al. Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy. Appl Health Econ Health Policy. 2012;10:163–73.CrossRefPubMed Viswanathan HN, Curtis JR, Yu J, White J, Merinar C, Stolshek BS, et al. Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy. Appl Health Econ Health Policy. 2012;10:163–73.CrossRefPubMed
12.
go back to reference Cooper C, Campion G, Melton III LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9.CrossRefPubMed Cooper C, Campion G, Melton III LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9.CrossRefPubMed
13.
go back to reference Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407–13.CrossRefPubMed Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407–13.CrossRefPubMed
14.
go back to reference Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int. 2004;15:897–902.CrossRefPubMed Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int. 2004;15:897–902.CrossRefPubMed
15.
go back to reference Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59–65.CrossRefPubMed Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59–65.CrossRefPubMed
16.
go back to reference Gènova-Maleras R, Catalá-López F, de Larrea-Baz NF, Álvarez-Martín E, Morant-Ginestar C. The burden of premature mortality in Spain using standard expected years of life lost: a population-based study. BMC Public Health. 2011;11:787.CrossRefPubMedPubMedCentral Gènova-Maleras R, Catalá-López F, de Larrea-Baz NF, Álvarez-Martín E, Morant-Ginestar C. The burden of premature mortality in Spain using standard expected years of life lost: a population-based study. BMC Public Health. 2011;11:787.CrossRefPubMedPubMedCentral
17.
go back to reference Gardner JW, Sanborn JS. Years of potential life lost (YPLL)–what does it measure? Epidemiology. 1990;1:322–9.CrossRefPubMed Gardner JW, Sanborn JS. Years of potential life lost (YPLL)–what does it measure? Epidemiology. 1990;1:322–9.CrossRefPubMed
18.
go back to reference Palacios S, Neyro JL, Puertas JC, Fernandez de Cabo S. Clinical profile of Spanish postmenopausal women with a diagnosis of osteoporosis and risk factors for endometrial pathology, breast cancer, and cardiovascular disease. Menopause. 2013;20(8):852–9.CrossRefPubMed Palacios S, Neyro JL, Puertas JC, Fernandez de Cabo S. Clinical profile of Spanish postmenopausal women with a diagnosis of osteoporosis and risk factors for endometrial pathology, breast cancer, and cardiovascular disease. Menopause. 2013;20(8):852–9.CrossRefPubMed
19.
go back to reference Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan. 2001;16:326–31.CrossRefPubMed Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan. 2001;16:326–31.CrossRefPubMed
20.
go back to reference Murray CJL, Acharya AK. Understanding DALYs. J Health Economics. 1997;16:703–30.CrossRef Murray CJL, Acharya AK. Understanding DALYs. J Health Economics. 1997;16:703–30.CrossRef
21.
go back to reference Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M. National Burden of Disease Studies: A Practical Guide. In: Global Program on Evidence for Health Policy. 20th ed. Geneva: World Health Organization; 2001. Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M. National Burden of Disease Studies: A Practical Guide. In: Global Program on Evidence for Health Policy. 20th ed. Geneva: World Health Organization; 2001.
23.
go back to reference Franks P, Lubetkin EI, Gold MR, Tancredi DJ, Jia H. Mapping the SF-12 to the EuroQol EQ-5D index in a national US sample. Med Decis Making. 2004;24:247–54.CrossRefPubMed Franks P, Lubetkin EI, Gold MR, Tancredi DJ, Jia H. Mapping the SF-12 to the EuroQol EQ-5D index in a national US sample. Med Decis Making. 2004;24:247–54.CrossRefPubMed
24.
go back to reference Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 2006;21(5):402–8.CrossRefPubMed Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 2006;21(5):402–8.CrossRefPubMed
25.
go back to reference Sanfélix-Genovés J, Hurtado I, Sanfélix-Gimeno G, Reig-Molla B, Peiró S. Impact of osteoporosis and vertebral fractures on quality-of-life. A population-based study in Valencia, Spain (The FRAVO Study). HQLO. 2011;9:20.PubMedPubMedCentral Sanfélix-Genovés J, Hurtado I, Sanfélix-Gimeno G, Reig-Molla B, Peiró S. Impact of osteoporosis and vertebral fractures on quality-of-life. A population-based study in Valencia, Spain (The FRAVO Study). HQLO. 2011;9:20.PubMedPubMedCentral
26.
go back to reference Cortet B, Blotman F, Debiais F, Huas D, Mercier F, Rousseaux C, et al. Management of osteoporosis and associated quality of life in post-menopausal women. BMC Musculoskelet Disord. 2011;12:7.CrossRefPubMedPubMedCentral Cortet B, Blotman F, Debiais F, Huas D, Mercier F, Rousseaux C, et al. Management of osteoporosis and associated quality of life in post-menopausal women. BMC Musculoskelet Disord. 2011;12:7.CrossRefPubMedPubMedCentral
27.
go back to reference Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnel I, Petterson C, et al. Mortality after Osteoporotic Fractures. Osteoporosis Int. 2004;15:38–42.CrossRef Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnel I, Petterson C, et al. Mortality after Osteoporotic Fractures. Osteoporosis Int. 2004;15:38–42.CrossRef
28.
go back to reference World Health Organization. The world health report: changing history. Geneva: World Health Organization; 2004. World Health Organization. The world health report: changing history. Geneva: World Health Organization; 2004.
29.
go back to reference Murray CJL, Lopez AP. Global and regional descriptive epidemiology of disability. Incidence, prevalence, health expectancies and years lived with disability. In: Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge: Cambridge University Press; 1996. p. 201–46. Murray CJL, Lopez AP. Global and regional descriptive epidemiology of disability. Incidence, prevalence, health expectancies and years lived with disability. In: Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge: Cambridge University Press; 1996. p. 201–46.
30.
go back to reference Murray CJL, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994;72(3):495–509.PubMedPubMedCentral Murray CJL, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994;72(3):495–509.PubMedPubMedCentral
31.
go back to reference Anand S, Hanson K. Disability-Adjusted Life Years: A Critical Review. J Health Econ. 1997;16(6):685–702.CrossRefPubMed Anand S, Hanson K. Disability-Adjusted Life Years: A Critical Review. J Health Econ. 1997;16(6):685–702.CrossRefPubMed
32.
go back to reference Bobadilla JL. “Priority Setting and Cost Effectiveness”. In: Janovsky K, editor. Health Policy and Systems Development: An Agenda for Research. Geneva: World Health Organization; 1996. p. 43–60. Bobadilla JL. “Priority Setting and Cost Effectiveness”. In: Janovsky K, editor. Health Policy and Systems Development: An Agenda for Research. Geneva: World Health Organization; 1996. p. 43–60.
33.
go back to reference Sambrook PN, Silverman SL, Cauley JA, Recknor C, Olson M, Su G, et al. Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone. 2011;48:1298–304.CrossRefPubMed Sambrook PN, Silverman SL, Cauley JA, Recknor C, Olson M, Su G, et al. Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone. 2011;48:1298–304.CrossRefPubMed
34.
go back to reference Mortimer D, Segal L. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Making. 2008;28:66–89.CrossRefPubMed Mortimer D, Segal L. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Making. 2008;28:66–89.CrossRefPubMed
35.
go back to reference Del Pino Montes J. Epidemiología de las fracturas osteoporóticas: las fracturas vertebrales y no vertebrales. Rev Osteoporos Metab Miner. 2010;2:S8–S12. Del Pino Montes J. Epidemiología de las fracturas osteoporóticas: las fracturas vertebrales y no vertebrales. Rev Osteoporos Metab Miner. 2010;2:S8–S12.
36.
go back to reference Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–33.CrossRefPubMed Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–33.CrossRefPubMed
Metadata
Title
Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study
Authors
Josep Darbà
Lisette Kaskens
Nuria Pérez-Álvarez
Santiago Palacios
José Luis Neyro
Javier Rejas
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1684-7

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue